Summary of Clinigen Group Plc (LON:CLIN) Ratings

May 17, 2018 - By Megan Stone

Clinigen Group Plc (LON:CLIN) Corporate Logo

Clinigen Group Plc (LON:CLIN) Ratings Coverage

In total 4 analysts cover Clinigen Group (LON:CLIN). “Buy” rating has 4, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 12 are the (LON:CLIN)’s analyst reports since November 29, 2017 according to StockzIntelligence Inc. On Thursday, January 18 the company was upgraded by Berenberg. On Wednesday, January 17 the stock of Clinigen Group Plc (LON:CLIN) has “Buy” rating given by Peel Hunt. On Wednesday, January 17 the stock has “Add” rating by Numis Securities. On Thursday, March 1 the stock of Clinigen Group Plc (LON:CLIN) earned “Buy” rating by Peel Hunt. In Wednesday, January 17 report N+1 Singer maintained the stock with “Buy” rating. In Tuesday, February 27 report Peel Hunt maintained it with “Buy” rating and GBX 1350 target. In Monday, March 19 report Peel Hunt maintained it with “Buy” rating and GBX 1350 target. On Thursday, February 1 the rating was maintained by Peel Hunt with “Buy”. In Tuesday, February 27 report Numis Securities maintained it with “Add” rating and GBX 1208 target. On Tuesday, March 27 the firm has “Buy” rating given by Berenberg. Listed here are Clinigen Group Plc (LON:CLIN) PTs and latest ratings.

04/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 Maintain
27/03/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1220.00 New Target: GBX 1160.00 Reiteration
19/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
27/02/2018 Broker: Numis Securities Rating: Add Old Target: GBX 1208.00 New Target: GBX 1208.00 Maintain
27/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
18/01/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1200.00 New Target: GBX 1220.00 Upgrade
17/01/2018 Broker: N+1 Singer Rating: Buy Old Target: GBX 1225.00 New Target: GBX 1225.00 Maintain
17/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain

CLIN is touching GBX 864 during the last trading session, after decreased 0.17%.Clinigen Group Plc has volume of 68,219 shares. Since May 17, 2017 CLIN has 0.00% and is . The stock underperformed the S&P 500 by 11.55%.

Clinigen Group plc operates as a specialty pharmaceutical and services firm in the United Kingdom, Europe, the United States, and internationally.The company has 1.06 billion GBP market cap. The Company’s Clinigen Clinical Trial Services business supplies and manages commercial medical products, including comparator drugs, adjuvant drugs, and rescue therapies for patients in clinical trials, as well as provides value added services.The P/E ratio is 77.14. The companyÂ’s Idis Managed Access business is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.